Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

712 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
Sadahira T, Wada K, Araki M, Ishii A, Takamoto A, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y, Kumon H; Okayama Urological Research Group (OURG). Sadahira T, et al. J Antimicrob Chemother. 2017 Feb;72(2):529-534. doi: 10.1093/jac/dkw424. Epub 2016 Oct 12. J Antimicrob Chemother. 2017. PMID: 27733519 Free article. Clinical Trial.
[UROLOGIC DISEASES IN THE EMERGENCY DEPARTMENT].
Tominaga Y, Katayama S, Ando E, Takenaka T, Kondo K. Tominaga Y, et al. Nihon Hinyokika Gakkai Zasshi. 2016;107(4):239-244. doi: 10.5980/jpnjurol.107.239. Nihon Hinyokika Gakkai Zasshi. 2016. PMID: 29070737 Free article. Japanese.
Clinical Efficacy and Safety of Sitafloxacin 200 mg Once Daily for Refractory Genitourinary Tract Infections.
Iwata T, Sadahira T, Maruyama Y, Sekito T, Yoshinaga K, Watari S, Nagao K, Kawada T, Tominaga Y, Nishimura S, Takamoto A, Sako T, Edamura K, Kobayashi Y, Araki M, Ishii A, Watanabe M, Watanabe T, Nasu Y, Wada K. Iwata T, et al. Among authors: tominaga y. Acta Med Okayama. 2021 Dec;75(6):763-766. doi: 10.18926/AMO/62820. Acta Med Okayama. 2021. PMID: 34955548 Free article. Clinical Trial.
Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab.
Katayama S, Iwata T, Kawada T, Okamoto Y, Sano Y, Kawago Y, Miyake S, Moriwake T, Kuinose A, Horikawa Y, Tsuboi K, Tsuboi I, Sakaeda K, Nakatsuka H, Takamoto A, Hirata T, Shirasaki Y, Yamasaki T, Morinaka H, Nagasaki N, Hara T, Ochi A, Okumura M, Watanabe T, Sekito T, Kawano K, Horii S, Yamanoi T, Nagao K, Yoshinaga K, Maruyama Y, Tominaga Y, Sadahira T, Nishimura S, Edamura K, Kobayashi T, Kusumi N, Kurose K, Yamamoto Y, Sugimoto M, Nakada T, Sasaki K, Takenaka T, Ebara S, Miyaji Y, Wada K, Kobayashi Y, Araki M. Katayama S, et al. Among authors: tominaga y. Urol Oncol. 2024 Mar;42(3):70.e11-70.e18. doi: 10.1016/j.urolonc.2023.11.009. Epub 2023 Dec 20. Urol Oncol. 2024. PMID: 38129282
The Diagnosis and Treatment Approach for Oligo-Recurrent and Oligo-Progressive Renal Cell Carcinoma.
Bekku K, Kawada T, Sekito T, Yoshinaga K, Maruyama Y, Yamanoi T, Tominaga Y, Sadahira T, Katayama S, Iwata T, Nishimura S, Edamura K, Kobayashi T, Kobayashi Y, Araki M, Niibe Y. Bekku K, et al. Among authors: tominaga y. Cancers (Basel). 2023 Dec 17;15(24):5873. doi: 10.3390/cancers15245873. Cancers (Basel). 2023. PMID: 38136417 Free PMC article. Review.
Trans men can achieve adequate muscular development through low-dose testosterone therapy: A long-term study on body composition changes.
Tominaga Y, Kobayashi T, Matsumoto Y, Moriwake T, Oshima Y, Okumura M, Horii S, Sadahira T, Katayama S, Iwata T, Nishimura S, Bekku K, Edamura K, Sugimoto M, Kobayashi Y, Watanabe M, Namba Y, Matsumoto Y, Nakatsuka M, Araki M. Tominaga Y, et al. Andrology. 2024 Apr 2. doi: 10.1111/andr.13640. Online ahead of print. Andrology. 2024. PMID: 38563871
712 results